Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study
ConclusionsResults from this post hoc analysis showed notable rates of efficacy in older patients taking adjunctive cenobamate. Rates of several individual TEAEs occurred more frequently in older patients. Further reductions in concomitant ASMs may be needed in older patients when starting cenobamate to avoid adverse effects such as somnolence, dizziness, and falls.Clinical Trials RegistrationClinicalTrials.gov NCT02535091.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Clinical Trials | Epilepsy | Geriatrics | International Medicine & Public Health | Respiratory Medicine | Study | WHO